Skip to main content

Table 1 Demographic characteristics of patients (enrolled n = 42, or completed the study n = 33), Cali-Colombia, 2011–2012

From: Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011–2012

Patient characteristics

n = 42

n = 33

Age, Median (Q1-Q3)

Total

34.0 (24–43)

37.0 (26.7–42.7)

Men

30.0 (24.0–41.0)

37.0 (26.9–42.4)

Women

34.5 (26.0–44.0)

35.6 (24.6–44.9)

Gender, n (%)

Male

28 (66.7)

21 (63.6)

Female

14 (33.3)

12 (36.4)

Ethnicity, n (%)

Black

7 (16.7)

6 (18.2)

Nonblack

35 (83.3)

27 (81.8)

Marital status, n (%)

Married

13 (31.0)

12 (36.4)

Single

29(69.0)

21 (63.6)

Education, n (%)

Elementary

10 (23.8)

8 (24.2)

High school

17 (40.5)

13 (39.4)

Technical education

6 (14.3)

5 (15.2)

University

9 (21.4)

7 (21.2)

Occupation, n (%)

Home

5 (11.9)

4 (12.1)

Student

6 (14.3)

3 (9.1)

Unemployed

3 (7.1)

2 (6.1)

Employed

28 (66.6)

24 (72.7)

Centers for Disease

Control and Prevention clinical stages

A

35 (83.3)

27 (81.8)

B

6 (14.3)

5 (15.2)

C

1 (2.4)

1 (3.0)

  1. Q quartile